Literature DB >> 27697457

Aryl hydrocarbon receptor-ligand axis mediates pulmonary fibroblast migration and differentiation through increased arachidonic acid metabolism.

Hsiang-Han Su1, Hsin-Ting Lin2, Jau-Ling Suen3, Chau Chyun Sheu4, Kazunari K Yokoyama5, Shau-Ku Huang6, Chih Mei Cheng7.   

Abstract

Pulmonary fibroblast migration and differentiation are critical events in fibrogenesis; meanwhile, fibrosis characterizes the pathology of many respiratory diseases. The role of aryl hydrocarbon receptor (AhR), a unique cellular chemical sensor, has been suggested in tissue fibrosis, but the mechanisms through which the AhR-ligand axis influences the fibrotic process remain undefined. In this study, the potential impact of the AhR-ligand axis on pulmonary fibroblast migration and differentiation was analyzed using human primary lung fibroblasts HFL-1 and CCL-202 cells. Boyden chamber-based cell migration assay showed that activated AhR in HFL-1cells significantly enhanced cell migration in response to 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin (TCDD), and a known AhR antagonist, CH223191, inhibited its migratory activity. Furthermore, the calcium mobilization and subsequent upregulated expression of arachidonic acid metabolizing enzymes, including cyclooxygenase2 (COX-2) and 5-lipoxygenase (5-LOX), were observed in TCDD-treated HFL-1 cells, concomitant with elevated levels of prostaglandin E2 (PGE2) and leukotriene B4 (LTB4) secretion. Also, significantly increased expression of α-smooth muscle actin α-SMA), a fibroblast differentiation marker, was also noted in TCDD-treated HFL-1 cells (p<0.05), resulting in a dynamic change in cytoskeleton protein levels and an increase in the nuclear translocation of the myocardin-related transcription factor. Moreover, the enhanced levels of α-SMA expression and fibroblast migration induced by TCDD, PGE2 and LTB4 were abrogated by selective inhibitors for COX-2 and 5-LOX. Knockdown of AhR by siRNA completely diminished intracellular calcium uptake and reduced α-SMA protein verified by promoter-reporter assays and chromatin immunoprecipitation. Taken together, our results suggested the importance of the AhR-ligand axis in fibroblast migration and differentiation through its capacity in enhancing arachidonic acid metabolism.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Alpha-SMA; Arachidonic acid; Aryl hydrocarbon receptor; Fibrosis; Myocardin-related transcription factor

Mesh:

Substances:

Year:  2016        PMID: 27697457     DOI: 10.1016/j.tox.2016.09.019

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  4 in total

Review 1.  The Aryl Hydrocarbon Receptor in Asthma: Friend or Foe?

Authors:  Odile Poulain-Godefroy; Mélodie Bouté; Julie Carrard; Daniel Alvarez-Simon; Anne Tsicopoulos; Patricia de Nadai
Journal:  Int J Mol Sci       Date:  2020-11-20       Impact factor: 5.923

2.  A prominent air pollutant, Indeno[1,2,3-cd]pyrene, enhances allergic lung inflammation via aryl hydrocarbon receptor.

Authors:  Tzu-Hsuan Wong; Chon-Lin Lee; Hsiang-Han Su; Chin-Lai Lee; Chao-Chien Wu; Chin-Chou Wang; Chau-Chyun Sheu; Ruay-Sheng Lai; Sum-Yee Leung; Chi-Cheng Lin; Yu-Feng Wei; Chien-Jen Wang; Yu-Chun Lin; Hua-Ling Chen; Ming-Shyan Huang; Jeng-Hsien Yen; Shau-Ku Huang; Jau-Ling Suen
Journal:  Sci Rep       Date:  2018-03-26       Impact factor: 4.379

3.  Quinolinate as a Marker for Kynurenine Metabolite Formation and the Unresolved Question of NAD+ Synthesis During Inflammation and Infection.

Authors:  John R Moffett; Peethambaran Arun; Narayanan Puthillathu; Ranjini Vengilote; John A Ives; Abdulla A-B Badawy; Aryan M Namboodiri
Journal:  Front Immunol       Date:  2020-02-21       Impact factor: 7.561

4.  Role of Resveratrol on Indoxyl Sulfate-Induced Endothelial Hyperpermeability via Aryl Hydrocarbon Receptor (AHR)/Src-Dependent Pathway.

Authors:  Eskedar Getachew Assefa; Qiaoqiao Yan; Siameregn Berhe Gezahegn; Maibouge Tanko Mahamane Salissou; Shuiqing He; Nannan Wu; Xuezhi Zuo; Chenjiang Ying
Journal:  Oxid Med Cell Longev       Date:  2019-11-27       Impact factor: 6.543

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.